| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 2,709.49 | 3,139.9 | 3,306.32 | 2,491.22 |
yoy growth (%) | -13.7 | -5.03 | 32.71 | -6.2 |
Raw materials | -1,450.36 | -1,684.42 | -1,780.39 | -1,307.02 |
As % of sales | 53.52 | 53.64 | 53.84 | 52.46 |
Employee costs | -220.67 | -264.9 | -264.41 | -226.3 |
As % of sales | 8.14 | 8.43 | 7.99 | 9.08 |
Other costs | -611.4 | -819.66 | -722.26 | -639.87 |
As % of sales (Other Cost) | 22.56 | 26.1 | 21.84 | 25.68 |
Operating profit | 427.05 | 370.9 | 539.24 | 318 |
OPM | 15.76 | 11.81 | 16.3 | 12.76 |
Depreciation | -99.97 | -107.39 | -82.59 | -81.12 |
Interest expense | -101.8 | -136.19 | -135.17 | -174.25 |
Other income | 47.88 | 173.23 | 46.21 | 51.89 |
Profit before tax | 273.16 | 300.54 | 367.69 | 114.52 |
Taxes | -58.69 | 22.3 | -104.25 | -35.32 |
Tax rate | -21.48 | 7.42 | -28.35 | -30.84 |
Minorities and other | 0 | 0 | 0 | 0 |
Adj. profit | 214.47 | 322.84 | 263.44 | 79.19 |
Exceptional items | 0 | -1.7 | 0 | 0 |
Net profit | 214.47 | 321.14 | 263.44 | 79.19 |
yoy growth (%) | -33.21 | 21.9 | 232.65 | 8.48 |
NPM | 7.91 | 10.22 | 7.96 | 3.17 |
This FDA audit confirms compliance with regulatory standards, enhancing the credibility of Jubilant's operations in the United States.
Jubilant Pharmova Ltd has gained a total of 126% in the last one year, and almost 75% gain since the beginning of the year.
Here are some of the stocks that may see significant price movement today: Tata Motors, Reliance Industries, IREDA, etc.
Drug company Jubilant Pharmova Ltd will acquire an 80% stake in Pierre Fabre Laboratories' Research & Development Centre in Saint Julien, France.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
